Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestrant With or Without Ganetespib in HR+, Metastatic Breast Cancer
NCT01560416Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Jun 2012
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ganetespib in breast cancer, sponsored by Dana-Farber Cancer Institute. Started Jun 2012; status: completed.
02
Drugs
ganetespib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01560416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01560416.